Intrinsic Value of S&P & Nasdaq Contact Us

Genprex, Inc. GNPX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
42/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Genprex, Inc. (GNPX) has a negative trailing P/E of -0.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -1,308.23%.

Criteria proven by this page:

  • VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -0.1); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -1,308.23%).
  • Trailing Earnings Yield -1,308.23% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 40/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
42/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — GNPX

Valuation Multiples
P/E (TTM)-0.1
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.16
P/S Ratio0.00
EV/EBITDA0.4
Per Share Data
EPS (TTM)$-17.40
Book Value / Share$8.54
Revenue / Share$0.00
FCF / Share$-16.42
Yields & Fair Value
Earnings Yield-1,308.23%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -12.3 0.36 31.24 0.00 -
2017 -16.3 0.66 125.90 0.00 -
2018 -1.2 -0.01 1.70 0.00 -
2019 -0.5 0.02 1.69 0.00 -
2020 -8.2 0.34 4.77 0.00 -
2021 -3.0 0.23 1.49 0.00 -
2022 -2.9 -0.23 3.12 0.00 -
2023 -0.4 -0.03 1.70 0.00 -
2024 -0.2 0.00 2.11 0.00 8,123.16%
2025 -0.1 0.00 0.21 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-15.26 $0.00 $-4.13M -
2017 $-11.53 $0.00 $-3.31M -
2018 $-35.94 $0.00 $-12.37M -
2019 $-26.59 $0.00 $-10.65M -
2020 $-20.18 $0.00 $-17.92M -
2021 $-16.64 $0.00 $-19.59M -
2022 $-24.58 $0.00 $-29.46M -
2023 $-22.56 $0.00 $-30.86M -
2024 $-5,339.07 $0.00 $-21.39B -
2025 $-17.40 $0.00 $-16.23M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-57.50 $-57.50 – $-57.50 $0.00 $0.00 – $0.00 1
2027 $-480.00 $-480.00 – $-480.00 $0.00 $0.00 – $0.00 1
2028 $-10.80 $-10.80 – $-10.80 $0.00 $0.00 – $0.00 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message